TNFRSF1A and neoplasm: Cytotoxic CD8+ T cells are the preferred immune cells targeting cancer, which exert specific cytotoxic effects by binding to the antigen peptide-MHC class I complex on the surface of tumor cells through perforin/granzyme pathway, Fas/FasL pathway, and TNF-TNFR pathway [39].